Hims & Hers vs LillyDirect (Zepbound) (2026): prices, structure, verdict
On tirzepatide, only LillyDirect (Zepbound)↗ has a rankable figure: $449 a month all-in; Hims & Hers↗ routes tirzepatide through brand channels without a single compounded cash price — its cost depends on coverage or the manufacturer programs (Zepbound vials $299–$449; Wegovy $349).
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
Hims & Hers
- Tirzepatide all-in
- brand channel
- Semaglutide all-in
- brand channel
- 12-mo tirzepatide (best path)
- —
- Membership
- none
- Shipping
- included
- Commitment
- plan recurs
- Cancellation
- plan recurs until cancelled
- Pharmacy
- ✔ brand fulfillment; compounded program closed to new patients
- States
- 50 states
- Insurance
- no
- Evidence
- no public price · 2026-08-05
LillyDirect (Zepbound)
- Tirzepatide all-in
- $449/mo
- Semaglutide all-in
- not offered
- 12-mo tirzepatide (best path)
- $5,388
- Membership
- none
- Shipping
- included (or same-day retail pickup)
- Commitment
- 45-day refill cadence to keep pricing
- Cancellation
- no subscription; refill-window rules apply
- Pharmacy
- ✔ Eli Lilly direct / retail partners
- States
- 50 states
- Insurance
- no
- Evidence
- source-verified · 2026-08-09
The two records, condensed
Hims & Hers: the record, condensed
On tirzepatide, Hims & Hers is a brand channel rather than a priced product: it prescribes the FDA-approved medication, and what you pay depends on coverage or the manufacturer cash programs (Zepbound (LillyDirect) at $299–$449).
Hims & Hers routes semaglutide through brand product — no single compounded cash figure exists to rank. The reference prices live one layer down: Wegovy (NovoCare↗), $199–$349 a month cash, or whatever your insurance turns those numbers into.
Operationally at Hims & Hers: shipping included; commitment plan recurs; cancellation plan recurs until cancelled; pharmacy named (brand fulfillment; compounded program closed to new patients); states: 50 states; evidence no public price, captured 2026-08-05. The full record with source and archive links: the Hims & Hers page · visit Hims & Hers ↗
LillyDirect (Zepbound): the record, condensed
On tirzepatide, the number that matters at LillyDirect (Zepbound) is $449 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. Pricing steps with the dose here: from $299 at entry to $449 at the 10 mg basis. Multiply the wrong one of those by twelve and your budget is off by $1,800 a year, which is why every ranking on this site uses the larger number.
The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.
Context for that figure: it ranks #0 of 17 in the verified tirzepatide index — $234/month above the floor (NexLife↗, $215) — and sits $0 over the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $5,388.
Operationally at LillyDirect (Zepbound): shipping included (or same-day retail pickup); commitment 45-day refill cadence to keep pricing; cancellation no subscription; refill-window rules apply; pharmacy named (Eli Lilly direct / retail partners); states: 50 states; evidence source-verified, captured 2026-08-09. The full record with source and archive links: the LillyDirect (Zepbound) page · visit LillyDirect (Zepbound) ↗
Everything besides the price
Coverage: both publish 50-state footprints, so geography does not break the tie.
Pharmacy transparency: both name fulfillment (brand fulfillment; compounded program closed to new patients / Eli Lilly direct / retail partners) — rare in this market, and it makes both independently checkable.
Exit terms: Hims & Hers — plan recurs; plan recurs until cancelled. LillyDirect (Zepbound) — 45-day refill cadence to keep pricing; no subscription; refill-window rules apply.
Evidence: Hims & Hers no public price (captured 2026-08-05); LillyDirect (Zepbound) source-verified (2026-08-09).
A rule that has held across this index: disclosure predicts disclosure. Whichever of these two publishes more — pharmacies, states, exit terms — is usually the one whose invoice matches its ad.
Switching between Hims & Hers and LillyDirect (Zepbound)
Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (Hims & Hers: plan recurs until cancelled; LillyDirect (Zepbound): no subscription; refill-window rules apply) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.
Which one, for whom
Cheapest tirzepatide month-to-month: LillyDirect (Zepbound) ($449).
Cheapest 12-month path: LillyDirect (Zepbound) at $5,388 (monthly billing).
Where a like-for-like price does not exist, the comparison becomes a disclosure contest: the program that answers the pharmacy, states, and maintenance-price questions plainly is the one whose other claims deserve weight.
Verdicts are computed from the records above — recompute them from the dataset. Full profiles: Hims & Hers · LillyDirect (Zepbound).
Frequently asked
Which is cheaper, Hims & Hers or LillyDirect (Zepbound)?
On tirzepatide, only LillyDirect (Zepbound) has a rankable figure: $449 a month all-in ; Hims & Hers routes tirzepatide through brand channels without a single compounded cash price — its cost depends on coverage or the manufacturer programs (Zepbound vials $299–$449; Wegovy $349).
Is there a membership fee at Hims & Hers or LillyDirect (Zepbound)?
Hims & Hers: none. LillyDirect (Zepbound): none.
Where do these numbers come from?
From each provider's own published pages, captured 2026-08-05 (Hims & Hers) and 2026-08-09 (LillyDirect (Zepbound)), normalized to the all-in maintenance basis and archived. Full records: the provider pages and the public dataset.
Is Hims & Hers or LillyDirect (Zepbound) dose-flat?
Hims & Hers: no flat structure verified — get the maintenance-dose price in writing. LillyDirect (Zepbound): no — assume the advertised figure is a starter price until the maintenance number is stated. Flat pricing turns the advertised number into a ceiling; tiered pricing makes it a floor.
Can I check both Hims & Hers and LillyDirect (Zepbound) against their sources?
Yes — that is the design. Each record carries a capture date (2026-08-05 / 2026-08-09), a source link, and an archive link in the database; the figures on this page regenerate from those records, so any discrepancy you find is reportable and fixable sitewide in one pass.
What states do Hims & Hers and LillyDirect (Zepbound) serve?
Hims & Hers: 50 states. LillyDirect (Zepbound): 50 states. Telehealth availability rides on clinician licensure and pharmacy permits, so for anything short of an explicit 50-state claim the enrollment flow is the final word; the state-by-state index adds the known exceptions.
Is shipping included at Hims & Hers and LillyDirect (Zepbound)?
Hims & Hers: included. LillyDirect (Zepbound): included (or same-day retail pickup). Cold-chain delivery is a real cost; programs that fold it into the all-in figure remove a checkout surprise, and any separate shipping line belongs in your comparison math before the prices above are treated as equivalent.
Which is more transparent, Hims & Hers or LillyDirect (Zepbound)?
On the checkable axes: pharmacy named — Hims & Hers yes (brand fulfillment; compounded program closed to new patients), LillyDirect (Zepbound) yes (Eli Lilly direct / retail partners); state list — Hims & Hers published, LillyDirect (Zepbound) published; cancellation terms — Hims & Hers published, LillyDirect (Zepbound) published; evidence — no public price vs source-verified. Disclosure predicts disclosure in this market, and the axis where one of these two goes quiet is usually where your intake questions should get loud.